Q3683260 (Q3683260): Difference between revisions
Jump to navigation
Jump to search
(Created a new Item: importing one item from France) |
(Changed label, description and/or aliases in en: Setting new description) |
||
description / en | description / en | ||
Project in France | Project Q3683260 in France |
Revision as of 12:55, 17 November 2021
Project Q3683260 in France
Language | Label | Description | Also known as |
---|---|---|---|
English | No label defined |
Project Q3683260 in France |
Statements
295,632.0 Euro
0 references
397,402.0 Euro
0 references
74.39 percent
0 references
1 January 2020
0 references
31 December 2022
0 references
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
0 references
BIOLICAN vise à développer un dispositif technologique innovant non invasif capable de détecter des signatures moléculaires spécifiques dans le sang des patients atteints de cancer du poumon afin d’améliorer le diagnostic précoce et la prise en charge de la maladie. (French)
0 references
Identifiers
MP0021775
0 references